A new study led by UCL academics found that at the peak of the COVID-19 pandemic, clinical research capacity may have been slashed by up to 87% in England. The research, published on PLOS One, estimated that at a population infection rate of 10% (at the peak in April, for over a month) less than 400
Eli Lilly has recently begun dosing patients in the world’s first trial for treatment designed to attack SARS-CoV-2, the virus that causes COVID-19. This investigational treatment, referred to as LY-CoV555, is the first produced as a result of the collaboration between Lilly and AbCellera to create antibody therapies for the prevention and treatment of COVID-19. Scientists developed
During times of change it can be challenging for organisations to focus on business strategy while maintaining employee engagement, productivity and wellness. Now more than ever, your leadership style, employer proposition and employee experience are important. As we all adapt to new ways of working implementing and adopting virtual interviews and onboarding are a challenge.
Yvette Cleland, Clinical Professionals Group CEO was recently asked by RIX (Recruitment Innovation Exchange) to provide her insights on the next biggest trends for 2020 for the staffing and recruitment industry, and to provide advice to firms looking to kickstart the new year. What industry trend is going to have the most impact for staffing and
Transgene has begun the New Year by starting trials of a new vaccine for ovarian and head and neck cancers. The French biotech is uniting with Japan based artificial intelligence (AI) specialist NEC on the new programme (TG4050) which according to the partners “moves therapeutic vaccination into the digital age.” TG4050 has been designed using
CAR-T therapies that are being developed by Bristol Myers Squibb and Janssen have all hit targets in early-mid-stage trials. Increasing hopes of new treatment options for difficult to treat blood cancers. Johnson & Johnson’s Janssen unveiled initial results from the Phase Ib/II CARTITUDE-1 study assessing the efficacy and safety of JNJ-68284528 (JNJ-4528) – an investigational B cell
According to a new report, the UK is ahead compared to the rest of Europe for early-stage clinical research into new medicines and vaccines, with more than 600 commercial clinical trials taking place in the NHS. The first annual report into clinical trials created by the Association of the British Pharmaceutical Industry (ABPI), stated that the UK is a
The saddest aspect of life right now is that science gathers knowledge faster than society gathers wisdom.
Our latest CPIA report features analysis on the Biotechnology sector. Clinical Professionals Group CEO, Yvette Cleland comments: “The UK biotech businesses focused within research and experimental development have risen by 65% since 2016 and the Golden Triangle of London/Oxford and Cambridge accounts for 35% of this concentration of companies. Annual investment reached 2.2 billion in
GSK announce promising results from a study conducted in partnership with non-profit scientific research organisation IAVI, that is investigating the efficacy of the company’s tuberculosis (TB) vaccine in HIV-negative adults with latent TB infection. The study was conducted across 11 sites throughout Kenya, South Africa and Zambia, which are all TB-endemic regions, and enrolled over
A pioneering clinical trial is set to investigate the use of cannabidiol (CBD) in people with Parkinson’s-related psychosis. Parkinson’s UK will be partnering with scientists at King’s College London in the first large-scale trial which aims to provide preliminary evidence for the safety and efficacy of CBD to alleviate the symptoms of Parkinson’s-related psychosis, characterised by hallucinations and delusions.